A Vaccine Against Cervical Cancer: Context for the Global Public Health Practitioner
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

A Vaccine Against Cervical Cancer: Context for the Global Public Health Practitioner
  • Published Date:

    December 27 2018

  • Source:
    Glob Health Sci Pract. 2018; 6(4):629-634
  • Language:
    English
Filetype[PDF-215.68 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 2.78 MB]
    Personal Author:
    Saraiya, Mona; Wharton, Melinda; Wentzensen, Nicolas; Garcia, Francisco; Richardson, Lisa C.; Iskander, John K.; Thorpe, Phoebe; Laird, Susan;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S,). Office of the Associate Director for Science.. Centers for Disease Control and Prevention (U.S,). Office of the Associate Director for Communication.. National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.. National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division..
    Published Date:
    January 15, 2019
    Series:
    Public health grand rounds ; 2019 January 15
    Description:
    Presented on Tuesday, January 15, 2019.Each year more than 4,000 U.S. women die from cervical cancer, the 4th most common cancer in women worldwide. Over 90% of cases of cervical cancer are associated with human papillomavirus (HPV) and the risk of c...
    File Type:
    Filetype[PDF - 2.78 MB]
  2. Filetype[PDF - 34.28 KB]
    Personal Author:
    Schiffman, *Mark; Saraiya, Mona;
    Published Date:
    Jun 06 2016
    Source:
    Lancet Infect Dis. 17(1):6-8.
    File Type:
    Filetype[PDF - 34.28 KB]
  3. Filetype[PDF - 365.12 KB]
    Personal Author:
    Chesson, Harrell W.; Ekwueme, Donatus U.; Saraiya, Mona; Markowitz, Lauri E.;
    Published Date:
    Feb 2008
    Source:
    Emerg Infect Dis. 14(2):244-251.
    Description:
    We describe a simplified model, based on the current economic and health effects of human papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old girls in the United States. Under base-case parameter values, the est...
    File Type:
    Filetype[PDF - 365.12 KB]
  4. Filetype[PDF - 943.18 KB]
    Personal Author:
    Senkomago, Virginia; Duran, Denise; Loharikar, Anagha; Hyde, Terri B.; Markowitz, Lauri E.; Unger, Elizabeth R.; Saraiya, Mona;
    Published Date:
    Dec 2017
    Source:
    Emerg Infect Dis. 23(Suppl 1):S101-S107.
    Description:
    Cervical cancer incidence and mortality rates are high, particularly in developing countries. Most cervical cancers can be prevented by human papillomavirus (HPV) vaccination, screening, and timely treatment. The US Centers for Disease Control and Pr...
    File Type:
    Filetype[PDF - 943.18 KB]
  5. Filetype[PDF - 30.91 KB]
    Personal Author:
    Schuchat, Anne
    Published Date:
    Feb 19 2015
    Source:
    N Engl J Med. 372(8):775-776.
    File Type:
    Filetype[PDF - 30.91 KB]